SCHEMBL26639153

SCHEMBL26639153

CCn1nc(-c2cscn2)cc1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4A O75164 1/20 0.44
▸ KDM4B O94953 1/20 0.44
▸ KDM5C P41229 1/20 0.44
▸ KDM5B Q9UGL1 1/20 0.44
▸ ECE1 P42892 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ SLC16A3 O15427 1/20 0.35
▸ SLC16A1 P53985 1/20 0.35
▸ MCTS1 Q9ULC4 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.34
▸ MARS1 P56192 2/20 0.33
▸ MAP3K5 Q99683 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ MAPKAPK2 P49137 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ GRN P28799 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31412344 0.87 KDM4A (0.38) KDM4AKDM4BKDM5CKDM5BECE1
SCHEMBL26639175 0.84 SMN1; SMN2 (0.47) POLBMAPTSMN1; SMN2
SCHEMBL26638882 0.81 KDM4A (0.48) KDM4AKDM4BKDM5CKDM5BECE1
SCHEMBL3646146 0.73 MARS1 (0.46) KDM4EMARS1GRNSORT1POLB
SCHEMBL17593153 0.73 SMN1; SMN2 (0.56) MARS1CA12CA1CA2CA9
SCHEMBL28014537 0.72 HDAC6 (0.46) MARS1HDAC6POLBMAPTSMN1; SMN2
SCHEMBL31412316 0.71 KDM4A (0.40) KDM4AKDM4BKDM5CKDM5BECE1
SCHEMBL28123448 0.71 SMN1; SMN2 (0.56) KDM4EHSD17B10MARS1HDAC6POLB
SCHEMBL3064335 0.70 L3MBTL1 (0.56) KDM4EHSD17B10ADORA2ASMN1; SMN2
SCHEMBL710008 0.70 MAPT (0.56) KDM4EGRNSORT1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12565494-B2 Inhibitors of human respiratory syncytial virus and metapneumovirus MERCK SHARP & DOHME LLC 2026-03-03 — — US disclosed
EP-4522604-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS Merck Sharp & Dohme LLC (US) 2025-03-19 — — EP disclosed
US-20250066323-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2025-02-27 — — US disclosed
WO-2025038786-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2025-02-20 — — WO disclosed
US-20230365551-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2023-11-16 — — US disclosed
WO-2023220225-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2023-11-16 — — WO disclosed
WO-2023220225-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2023-11-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066323-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS METAP1, SARS1, RTF1 KDM4A 3943/4885KDM4B 3866/4885KDM5C 4616/4885
US-20230365551-A1 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS NHERF1, ACE, METAP1 KDM4A 4244/4885KDM4B 4099/4885KDM5C 4575/4885
US-12565494-B2 Inhibitors of human respiratory syncytial virus and metapneumovirus NHERF1, ZC3HAV1, SARS1 KDM4A 3945/4885KDM4B 3834/4885KDM5C 3734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback